Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women"
- PMID: 34326206
- DOI: 10.1126/science.abj1696
Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women"
Abstract
Yoshino et al (Reports, 11 June 2021, p. 1224) have reported that nicotinamide mononucleotide (NMN) increases muscle insulin sensitivity in prediabetic women. However, the 13 women who received NMN had hepatic lipid content of 6.3 ± 1.2%, whereas the 12 in the placebo group had 14.8 ± 2.0% (P = 0.003). Given that a target of NMN is liver fat clearance, this was not an effectively randomized trial.
Copyright © 2021, American Association for the Advancement of Science.
Comment in
-
Response to Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women".Science. 2021 Jul 30;373(6554):eabj7375. doi: 10.1126/science.abj7375. Science. 2021. PMID: 34326209
Comment on
-
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.Science. 2021 Jun 11;372(6547):1224-1229. doi: 10.1126/science.abe9985. Epub 2021 Apr 22. Science. 2021. PMID: 33888596 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
